» Authors » Doris Henne-Bruns

Doris Henne-Bruns

Explore the profile of Doris Henne-Bruns including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 152
Citations 1862
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Bauer K, Buchler P, Henne-Bruns D, Manzini G
Ann Med Surg (Lond) . 2023 Jul; 85(7):3284-3290. PMID: 37427179
Materials And Methods: The authors retrospectively analyzed the OS of all patients who underwent pancreatic resection at their clinic because of ductal adenocarcinoma between January 2013 and December 2020 in...
2.
Shen X, Kretz A, Schneider S, Knippschild U, Henne-Bruns D, Kornmann M, et al.
Biomedicines . 2023 Mar; 11(3). PMID: 36979907
Treatment options for colorectal cancer (CRC), especially in advanced stages are still insufficient. There, the discovery of Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) was a bright spot. However, most...
3.
Scheele J, Lemke J, Wittau M, Sander S, Henne-Bruns D, Kornmann M
Visc Med . 2022 May; 38(2):138-149. PMID: 35614891
Introduction: Compared to abdominoperineal resection (APR), sphincter preservation using low anterior resection (AR) for rectal cancer (RC) implies the risk of impaired functional outcome and postoperative complications associated with a...
4.
Bauer K, Henne-Bruns D, Manzini G
Int J Risk Saf Med . 2021 Dec; 34(1):29-40. PMID: 34897105
Background: Since randomized controlled trials have indicated that adjuvant chemotherapy prolongs survival and reduces recurrence rates after surgical resection of pancreatic adenocarcinoma, a gemcitabine based chemotherapy has become part of...
5.
Traub B, Haggenmuller B, Baumann L, Lemke J, Henne-Bruns D, Wittau M
Int J Surg Case Rep . 2021 Dec; 89:106634. PMID: 34864261
Introduction And Importance: Unclear retroperitoneal tumors impose major challenges for clinicians. Tumors can originate primarily from retroperitoneal tissue or secondarily invade into the retroperitoneum. While benign lesions also occur, malignant...
6.
Ruff J, Kretz A, Kornmann M, Henne-Bruns D, Lemke J, Traub B
Anticancer Res . 2021 Dec; 41(12):5973-5985. PMID: 34848451
Background/aim: This study was designed to analyse the effects of the novel, orally bioavailable CDK9-inhibitor Atuveciclib (BAY 1143572) in combination with tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) on pancreatic ductal...
7.
Lakemeyer L, Sander S, Wittau M, Henne-Bruns D, Kornmann M, Lemke J
Diseases . 2021 Apr; 9(1). PMID: 33802962
Colorectal cancer (CRC) is the third most common cancer worldwide. A diagnosis at early stages with enhanced screening methods is vital as metastases and recurrences increase mortality. The aim of...
8.
Tian X, Traub B, Shi J, Huber N, Schreiner S, Chen G, et al.
Cancer Gene Ther . 2021 Feb; 29(1):73-86. PMID: 33526844
The c-Jun N-terminal protein kinases (JNKs) JNK1 and JNK2 can act as either tumor suppressors or pro-oncogenic kinases in human cancers. The isoform-specific roles for JNK1 and JNK2 in human...
9.
Grimm J, Nell J, Hillenbrand A, Henne-Bruns D, Schmidberger J, Kratzer W, et al.
PLoS Negl Trop Dis . 2020 Dec; 14(12):e0008921. PMID: 33370302
Background: Alveolar (AE) and cystic echinococcosis (CE) in humans are caused by the metacestode of the tapeworms Echinococcus multilocularis and Echinococcus granulosus sensu lato (s.l.). Immunohistochemistry with the monoclonal antibodies...
10.
Tian X, Traub B, Xie X, Zhou S, Henne-Bruns D, Knippschild U, et al.
Anticancer Res . 2020 Sep; 40(10):5545-5556. PMID: 32988878
Background/aim: The p38 family of mitogen-activated protein kinases (MAPK) includes four isoforms: p38α, -β, -γ and -δ. The aim of this study was to elucidate possible functions of p38α and...